About Christopher de Souza
Form D filings for Gila Therapeutics from 2016 to 2023 list Christopher de Souza as director.
Christopher de Souza first appears on SEC filings in 2016.
Experience
This experience comes from SEC filings. The years are when the filings name Christopher de Souza in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Christopher de Souza works with at each company, as listed on that company's latest Form D.
Gila Therapeutics, Inc. · Form D, Dec 6, 2023
TB
Timothy Barberich
Director
PT
Praveen Tyle
Director
JF
Jon Freeman
Executive officer
TV
Thomas Vasicek
Executive officer
RH
Richard Horan
Director
SS
Scott Schorer
Cief Executive Officer and director
SK
Sangeeta Kashyap
Executive officer